Factories in orbit and what they bring back to Earth
Why the First Space Factories Pay Off in Tiny Products and in Lessons That Come Back to Earth
This page is educational framing about space manufacturing and research. It is not investment, engineering, or medical advice, and it is not a product or company recommendation.
Factories in orbit are usually pictured as giant stations building ships and habitats. This page argues for a different and more useful picture. The first space factories that actually work make very small, very valuable things, and their biggest payoff so far is knowledge that lets factories on the ground do better work. That matters for futurism and for the move from scarcity toward abundance, because knowledge is not used up when it is shared. A process learned once in orbit can be repeated on Earth millions of times without paying for another launch.
The thesis in one sentence: the near-term value of manufacturing in microgravity comes from products where weight barely matters and from lessons that move production back down to Earth, not from shipping bulk goods out of the sky.
What gravity spoils on Earth
On Earth, gravity drives three effects that get in the way of some delicate manufacturing. Heavier particles sink, which is called sedimentation. Warm fluid rises and cool fluid falls, which is called convection. Lighter material floats, which is buoyancy. For most products these effects do not matter. For a few, they are the main reason the product is flawed.
Growing crystals is a clear case. Many medicines are made, stored, or delivered as crystals, and the size and uniformity of those crystals changes how a drug dissolves, how thick a liquid dose becomes, and whether it can pass through a needle. Some special glass is another case. When certain glass mixtures are cooled, tiny crystals form inside them, and those crystals scatter light and make the material brittle. In orbit, objects are in continuous free fall, so sedimentation and convection nearly disappear. That gives researchers a way to see what a process looks like when gravity is removed from the problem.
Three real stories
Merck and a cancer medicine
Researchers at Merck flew crystallization experiments with the antibody medicine pembrolizumab to the International Space Station on a 2017 cargo flight. Their 2019 paper in npj Microgravity reported that the crystals grown in orbit came out at one uniform size of about 39 micrometers, while ground controls produced a messy mix of 13 and 102 micrometer particles. The space samples were also less viscous and settled more evenly.[1]
The surprising part is what happened next. The team did not build a factory in space. They used what orbit taught them, namely that sedimentation and temperature gradients controlled the result, and copied those conditions on the ground with a slowly rotating mixer and a controlled temperature change. That ground process produced uniform crystals of about 1 to 5 micrometers with a thickness suitable for an injection.[1] NASA reported in January 2026 that this early space research informed a version of the medicine given by injection under the skin, approved by the U.S. Food and Drug Administration in September 2025. NASA describes the new form as taking about one minute every three weeks, compared with infusions that once took up to two hours.[2]
In other words, one of the clearest medical results of orbital manufacturing so far was a better Earth factory process and less time in a clinic chair for patients.
Optical fiber that grows crystals on the ground
ZBLAN is a glass made from fluorides of zirconium, barium, lanthanum, sodium, and aluminum. NASA explains that it can carry light over a broader range than ordinary silica fiber, but when it is drawn into fiber on the ground, crystals form that scatter signals and weaken it. From mid-February to mid-March 2024, a machine built by the startup Flawless Photonics drew more than 11.9 kilometers of ZBLAN fiber aboard the space station, including more than 1,141 meters in one day, compared with a prior record of about 25 meters for fiber made in space.[3]
Fiber is a good fit for orbit because it is light for its value. The company founder told The Register that it had filled orders for fiber priced at about 1,000 dollars per meter, which he said matched the going rate for ZBLAN made on the ground.[4] NASA noted that the fiber still had to be analyzed back on Earth to show whether it reached the goal of ten times better quality than ground fiber.[3] Making long lengths is a real step. Proving the product is better is a separate step.
A capsule that lands on its own
The space station is shared, crowded, and depends on astronaut time. Varda Space Industries tried another route: a small automated capsule that processes material in orbit and then falls back to Earth. Its W-1 capsule launched on June 12, 2023, grew crystals of a hard-to-make form of the HIV drug ritonavir, and landed at the Utah Test and Training Range on February 21, 2024.[5] Its partner Improved Pharma reported that the most stable form of the drug was converted to the less stable Form III in orbit and that control samples came back without changing form.[6]
The capsule sat in orbit for months longer than the processing took, while the company worked through reentry approval with the Federal Aviation Administration.[7] That delay is a useful lesson in itself. Getting things back down safely and legally can be as hard as making them.
Why this points toward abundance
The pattern across these stories is that orbit works best as a laboratory that removes one variable. Once researchers learn which variable mattered, the knowledge can often be copied on the ground at ordinary cost. That is an abundance pattern. A launch is scarce and expensive, but an insight is non-rival. Many factories can use it at the same time, and it does not wear out.
The second pattern is weight. Even as reusable rockets lower the price of reaching orbit, carrying things up and down still costs a great deal per kilogram. The products that make sense first are those where a small mass carries a large value, such as drug crystals and specialty fiber. Bulk goods such as steel or concrete for Earth will not come from orbit in any foreseeable future. For building in space itself, using material already found there, such as water from asteroids, is the more promising path, as discussed in Asteroid mining.
A third pattern concerns who benefits. If space research mainly improves processes on the ground, its gains can spread through ordinary factories, generic production, and competition, rather than staying locked inside a few orbital facilities. Readers interested in how that fits with factories closer to home can compare it with Onshoring manufacturing.
Limits and open questions
- Many space experiments are small, single runs. A striking result in orbit still has to be repeated, scaled, and checked by independent testing.
- Company statements about markets and prices are claims by interested parties, not independent proof of demand.
- Better crystals or fiber do not automatically mean lower prices for the public. Patents, regulation, and pricing decisions shape who gains.
- Return trips raise safety, licensing, and debris questions that are still being worked out.
- Microgravity is not a general cure for manufacturing problems. For most products, gravity is irrelevant and orbit only adds cost.
Discussion questions, essay ideas, and learning related AI prompt ideas
- Explain why a process learned in orbit and copied on Earth may do more for abundance than a factory that stays in orbit.
- Compare the Merck crystal story with the ZBLAN fiber story and identify what each shows about the difference between making a product and proving it is better.
- Describe which kinds of products have enough value per kilogram to justify the cost of a round trip to orbit, and which never will.
- Evaluate how reentry rules and safety approvals should balance public protection with the speed of research.
- Design a research program that uses microgravity only to find the hidden variable in a manufacturing problem and then moves production back to the ground.
- Discuss who should share in the gains when public space station access helps a private company improve a product.
See also
- Reusable rockets
- Asteroid mining
- Lunar lava tubes
- Fungi houses in space
- Onshoring manufacturing
- Manufacturing
- Space travel
References
- ↑ 1.0 1.1 Reichert P. et al. "Pembrolizumab microgravity crystallization experimentation." npj Microgravity 5, 28 (2019). https://www.nature.com/articles/s41526-019-0090-3
- ↑ NASA. "Space Station Research Informs New FDA-Approved Cancer Therapy." January 6, 2026. https://www.nasa.gov/missions/station/iss-research/space-station-research-informs-new-fda-approved-cancer-therapy/
- ↑ 3.0 3.1 NASA. "Optical Fiber Production." Science in Space, March 2024. https://www.nasa.gov/missions/station/iss-research/optical-fiber-production/
- ↑ The Register. "Fiber optics made in space may be the future of photonics." April 23, 2024. https://www.theregister.com/on-prem/2024/04/23/fiber-optics-made-in-space-may-be-the-future-of-photonics/306516
- ↑ Varda Space Industries. "W-1." https://www.varda.com/mission/w-1
- ↑ Improved Pharma. "Mission success: Ritonavir crystallization experiments conducted in space worked flawlessly." March 22, 2024. https://improvedpharma.com/mission-success-ritonavir-crystallization-experiments-conducted-space-worked-flawlessly/
- ↑ Payload. "Varda Releases Results of In-Space Pharma Mission." 2024. https://payloadspace.com/varda-releases-results-of-in-space-pharma-mission/